1. Home
  2. GNLX vs FNGR Comparison

GNLX vs FNGR Comparison

Compare GNLX & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • FNGR
  • Stock Information
  • Founded
  • GNLX 2001
  • FNGR 2016
  • Country
  • GNLX United States
  • FNGR Singapore
  • Employees
  • GNLX N/A
  • FNGR N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • GNLX Health Care
  • FNGR Technology
  • Exchange
  • GNLX Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • GNLX 129.9M
  • FNGR 113.4M
  • IPO Year
  • GNLX 2023
  • FNGR N/A
  • Fundamental
  • Price
  • GNLX $3.53
  • FNGR $1.71
  • Analyst Decision
  • GNLX Strong Buy
  • FNGR
  • Analyst Count
  • GNLX 5
  • FNGR 0
  • Target Price
  • GNLX $16.20
  • FNGR N/A
  • AVG Volume (30 Days)
  • GNLX 153.8K
  • FNGR 560.0K
  • Earning Date
  • GNLX 08-13-2025
  • FNGR 07-15-2025
  • Dividend Yield
  • GNLX N/A
  • FNGR N/A
  • EPS Growth
  • GNLX N/A
  • FNGR N/A
  • EPS
  • GNLX N/A
  • FNGR N/A
  • Revenue
  • GNLX N/A
  • FNGR $35,692,374.00
  • Revenue This Year
  • GNLX N/A
  • FNGR N/A
  • Revenue Next Year
  • GNLX N/A
  • FNGR N/A
  • P/E Ratio
  • GNLX N/A
  • FNGR N/A
  • Revenue Growth
  • GNLX N/A
  • FNGR 11.55
  • 52 Week Low
  • GNLX $1.60
  • FNGR $1.03
  • 52 Week High
  • GNLX $5.89
  • FNGR $5.20
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 58.36
  • FNGR 42.82
  • Support Level
  • GNLX $3.30
  • FNGR $1.43
  • Resistance Level
  • GNLX $3.60
  • FNGR $2.35
  • Average True Range (ATR)
  • GNLX 0.26
  • FNGR 0.17
  • MACD
  • GNLX 0.00
  • FNGR 0.04
  • Stochastic Oscillator
  • GNLX 75.71
  • FNGR 30.43

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: